| Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has NHS dm+d (dictionary of medicines and devices) dose form indicator |
Discrete dose form indicator |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has NHS dm+d (dictionary of medicines and devices) controlled drug category |
Controlled drug category No Controlled Drug Status |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration |
Intravenous route |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route |
solutioninjection.intravenous ontology form and route |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Is a |
Eptacog alfa (activated) |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
VMP non-availability indicator |
Not available |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Is a |
Product containing eptacog alfa (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has active ingredient |
Eptacog alfa |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
VMP prescribing status (attribute) |
VMP valid as a prescribable product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
VMP non-availability indicator |
Available |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has manufactured dose form |
Powder and solvent for solution for injection |
false |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has specific active ingredient |
Eptacog alfa |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has dispensed dose form |
Powder and solvent for solution for injection |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Is a |
Virtual medicinal product |
true |
Inferred relationship |
Existential restriction modifier |
|
|
| Eptacog alfa (activated) 5mg (250,000unit) powder and solvent for solution for injection vials |
Has manufactured dose form |
Powder and solvent for solution for injection |
false |
Inferred relationship |
Existential restriction modifier |
|
|
FHIR